Thus, while SEL1LB and –C are generated from alternatively-spliced mRNAs expressed at low levels and up-modulated in cancer cells (Figure S6) and under ER stress [26], the two new soluble SEL1L forms, abundantly expressed in cancer cells, could likely originate from proteolytic cleavage of SEL1LA. The gene discussed is SEL1L; the disease is cancer.